Keracnyl PP+ Anti-Blemish Cream
32.99 CAD
https://product-images.metro.ca/images/h64/h14/13776487874590.jpg Keracnyl PP+ anti-imperfection cream promotes the reduction of acne-prone skin inflamed spots. Recommended by Canadian dermatologists. Keracnyl PP+ anti-imperfection cream promotes the reduction of inflamed spotsHelps reduce blemishes from 7 days¹Prescribed by dermatologists, it compensates for dryness and flaking due to drug treatments² and immediately soothes.24H³ hydrationThis non-greasy and non-sticky treatment, suitable for adults and adolescents from 12 years old, also limits the appearance of scars¹Clinical study of tolerance and efficacy in monotherapy carried out on 41 subjects, between 12 and 35 years old, presenting mild to moderate acne with at least post-inflammatory erythema (PPE) and/or post-inflammatory hyperpigmentation (PIH). Study period (D1-D57): 2 applications per day morning and evening.²Tolerance study in combination with topical treatments carried out on 39 subjects, between 12 and 40 years old. Study period (D1-D29): 2 applications per day morning and evening.³Clinical study in monotherapy carried out on 19 subjects, between 23 and 57 years old, single application in the morning and measurement of IH kinetics over 24 hours. Ducray 673914402910
Ducray Keracnyl PP+ Anti-Blemish Cream 30 mL
Ducray

Keracnyl PP+ Anti-Blemish Cream

30 mL

Keracnyl PP+ anti-imperfection cream promotes the reduction of acne-prone skin inflamed spots. Recommended by Canadian dermatologists. Keracnyl PP+ anti-imperfection cream promotes the reduction of inflamed spotsHelps reduce blemishes from 7 days¹Prescribed by dermatologists, it compensates for dryness and flaking due to drug treatments² and immediately soothes.24H³ hydrationThis non-greasy and non-sticky treatment, suitable for adults and adolescents from 12 years old, also limits the appearance of scars¹Clinical study of tolerance and efficacy in monotherapy carried out on 41 subjects, between 12 and 35 years old, presenting mild to moderate acne with at least post-inflammatory erythema (PPE) and/or post-inflammatory hyperpigmentation (PIH). Study period (D1-D57): 2 applications per day morning and evening.²Tolerance study in combination with topical treatments carried out on 39 subjects, between 12 and 40 years old. Study period (D1-D29): 2 applications per day morning and evening.³Clinical study in monotherapy carried out on 19 subjects, between 23 and 57 years old, single application in the morning and measurement of IH kinetics over 24 hours.

Product Number: 673914402910

Ducray Keracnyl PP+ Anti-Blemish Cream 30 mL

Keracnyl PP+ Anti-Blemish Cream

1